C07D 271/08
1,2,5-oxadiazoles
Official title: 1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles
C07D271/08 (1,2,5-oxadiazoles) appears on 187 US grants and 182 published applications in this corpus.
Search patents in C07D- Granted patents
- 187
- Published applications
- 182
- Assignees
- 116
- Inventors
- 618
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 4 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 6 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 4 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 5 | 0 |
| 2002 | 6 | 3 |
| 2003 | 2 | 3 |
| 2004 | 2 | 5 |
| 2005 | 1 | 3 |
| 2006 | 2 | 4 |
| 2007 | 2 | 7 |
| 2008 | 4 | 11 |
| 2009 | 4 | 8 |
| 2010 | 5 | 8 |
| 2011 | 4 | 7 |
| 2012 | 3 | 8 |
| 2013 | 7 | 7 |
| 2014 | 12 | 15 |
| 2015 | 12 | 9 |
| 2016 | 7 | 8 |
| 2017 | 7 | 10 |
| 2018 | 11 | 13 |
| 2019 | 8 | 9 |
| 2020 | 7 | 10 |
| 2021 | 14 | 11 |
| 2022 | 5 | 4 |
| 2023 | 3 | 5 |
| 2024 | 1 | 6 |
| 2025 | 1 | 4 |
| 2026 | 6 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Compound, cellular vesicle staining agent, and method of fluorescent staining for cellular vesicles11 Aug 2026US 12,704,443 B2National University Corporation Tokai National Higher Education and Research System
- Substituted isophthalic acid diamides16 Jun 2026US 12,655,116 B2Bayer Aktiengesellschaft
- Aryl formamide compound containing chiral sulfur oxide or salt thereof, preparation method, herbicidal composition and use thereof2 Jun 2026US 12,643,871 B2Qingdao Kingagroot Chemical Compound Co., Ltd.
- 14-chloro-β-elemene nitric oxide donor derivative and preparation method and use thereof12 May 2026US 12,624,012 B2Hangzhou Normal University
- Process for the preparation of (6s,9r)-3-oxo-3,5,6,7,8,9-hexahydro-2h-6,9-epiminocyclohepta[c]pyridazine-10-carboxamide derivatives3 Sep 2026US 2026/0258043 A1Pathios Therapeutics Limited
- A method of treating seeds and seeds produced thereby13 Aug 2026US 2026/0231848 A1Cyprus University of Technology
- Dihydroindene derivatives as malt1 inhibitors2 Jul 2026US 2026/0184687 A1C4X Discovery Limited
- Small-molecule activators of mycobacterium tuberculosis adenylyl cyclase19 Feb 2026US 2026/0048047 A1
- 4-Methylsulfonylbenzamide Compound, Preparation Method, Herbicidal Composition And Use10 Jul 2025US 2025/0223268 A1Jiangsu Flag Chemical Industry Co., Ltd.
Most cited
By later US patents
- Sulfonamide inhibitors of aspartyl protease147US 5,585,397 AVertex Pharmaceuticals Incorporated · 1996
- N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives56US 7,176,242 B2Elan Pharmaceuticals, Inc. · 2007
- THF-containing sulfonamide inhibitors of aspartyl protease53US 5,723,490 AVertex Pharmaceuticals Incorporated · 1998
- Nitric oxide donor neprilysin inhibitors53US 9,045,443 B2Theravance Biopharma R&D IP, LLC · 2015
- Sulfonamide inhibitors of aspartyl protease50US 6,372,778 B1Vertex Pharmaceuticals Incorporated · 2002